搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
7 小时
Could lymph node surgery be the answer for treating Alzheimer’s disease?
A clinical trial in Chinese public hospitals is showing promise, but experts stress that further studies are needed.
El País in English
11 小时
Stamp-sized microchip that imitates the human brain could speed up treatments for Alzheimer’s
Advanced brain-on-a-chip technology developed by EU-funded researchers helps make potential treatments for neurological ...
Rolling Out
17 小时
5 ways this cancer drug could revolutionize Alzheimer’s treatment
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
protothema.gr
5 天
The new drugs coming in 2025 for obesity, alzheimer’s, cancer, and chronic pain
The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...
Knowridge
1 天
Common sleep drugs are linked to dementia, study finds
Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...
来自MSN
5 天
This Surprising Medication May Lower Alzheimer's Risk
A common medication may help prevent dementia and Alzheimer's disease—but researchers are still trying to figure out why, and ...
alzheimersnewstoday
2 天
Axsome to ask FDA to approve AXS-05 for Alzheimer’s agitation
The company recently announced results from two Phase 3 trials of AXS-05 for agitation. ACCORD-2, hit its main goal, but ...
4 天
Ozempic and Similar Drugs May Offer Health Benefits Beyond Weight Loss, Including Reduced ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
5 天
on MSN
Axsome reports mixed results for Alzheimer's agitation drug
Axsome Therapeutics (AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05 in the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈